The usefulness of serum biomarkers in the early stages of diabetic retinopathy: results of the EUROCONDOR clinical trial

Thumbnail

peer-reviewed

Erstveröffentlichung
2020-04-24
Authors
Hernández, Cristina
Porta, Massimo
Bandello, Francesco
Grauslund, Jakob
Harding, Simon P.
et al.
Wissenschaftlicher Artikel


Published in
Journal of Clinical Medicine ; 9 (2020), 4. - Art.-Nr. 1233. - eISSN 2077-0383
Link to original publication
https://dx.doi.org/10.3390/jcm9041233
Institutions
UKU. Klinik für Augenheilkunde
External cooperations
Vall d'Hebron Research Institute (VHIR)
University of Turin
Università Vita-Salute San Raffaele
Syddansk Universitet
University of Liverpool,
et al.
Document version
published version (publisher's PDF)
EU Project uulm
EUROCONDOR / European Consortium for the Early Treatment of Diabetic Retinopathy / EC / FP7 / 278040
Subject headings
[GND]: Retinopathia diabetica | Biomarker | Dimethylarginin <N,N->
[MeSH]: Diabetic retinopathy | Retinal degeneration | Biomarkers | Laminin
[Free subject headings]: diabetic retinopathy | retinal neurodegeneration | serum biomarkers | carboxy methyl lysine | asymmetric dimethylarginine
[DDC subject group]: DDC 610 / Medicine & health
License
CC BY 4.0 International
https://creativecommons.org/licenses/by/4.0/
Metadata
Show full item record

DOI & citation

Please use this identifier to cite or link to this item: http://dx.doi.org/10.18725/OPARU-42297

Hernández, Cristina et al. (2022): The usefulness of serum biomarkers in the early stages of diabetic retinopathy: results of the EUROCONDOR clinical trial. Open Access Repositorium der Universität Ulm und Technischen Hochschule Ulm. http://dx.doi.org/10.18725/OPARU-42297
Citation formatter >